$MORF + 134% today.

$MORF did a very good spike today on 3 different news.  Yes! 3 They really want to be sure to get some massive impact on the market today with these series of press releases. Morphic Holding is a biopharma company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases   They announce the highlights of financial results for 2020. Here is the link of the press release.   They report positive ...

Read More

$PAND +133% today an acquisition news

$PAND who is a clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases just today after Merck & Co ($MRK) offer $60 per share in cash. Here is the link of the press release. Here is the graph of the day.   Here is the 30-day overview.

Read More

$GME +103% again on the day!

Here we are again with GameStop  who hit again at  the end of the day on big volume! Same kind of manipulation than last time and same dangers. PLEASE if you are small investors and you invest at high price on the last bubble, make your money and GET OUT before to lose everything. This kind of market manipulation will work, 1 time, 2 times... perhaps 3 times...  but those who will buy ...

Read More

$GTEC +95%

$GTEC who is a Chinese producer of material in handling industry gets a big boost of price on BIG volume this morning after they announced a cooperation agreement with China-based SOCMA to use some technologies to support EV production in the US. For a stock who generally get a daily volume of 200 000 shares exchanges, we close the day at 64 Million shares. With this kind of volume, everything can fly… Here ...

Read More

$LODE +157%

$LODE who want to become an emerging leader in climate-smart mineral development. They wan to focus on minerals and metals that are essential to meeting the rapidly increasing demand for clean energy technology but also are in precious metal. We get this big morning gap up on news about securing the rights to a majority equity stake in LINICO Corporation who is a lithium-ion battery recycling company. Here is the link for the ...

Read More

$CLPS + 121% today.

$CLPS, who is a global information technology (“IT”), consulting and solutions service provider focused on delivering services to global institutions in banking, insurance and financial sectors, in the US, Europe, Australia, Southeast Asia and, Hong Kong and their PRC-based IT centers. They did very well today on latest news related to an agreement with a well-known U.S. digital payment platform. Here is the link of the press release. Here is the graph of ...

Read More

$SCKT +538% today!

$SCKT who is a producer of data capture product make some big waves on high volume on  news related to  its new DuraSled offering, which is an enterprise-grade barcode scanner for Apple Inc.'s iPhone 12s and fourth quarter conferences news. I still track this one for a +133% gain in 1 day. Here is the link of the previous post. Here is the graph of the day. Here is the 30 day overview.

Read More

$BPTH +126%

$BPTH is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. They release today the news of a US patent for their technology. Here is the link of the news. I saved the graph of the day here.   Here is the 30 day graph.

Read More

$ANCN +184%

$ANCN is on fire today! we get a +184% gain on the news of last week that its first patient has been enrolled in a clinical trial for a treatment aimed at “liver, skin, and lung fibrosis-related diseases such as PSC and systemic sclerosis .” Here is the link of the press release. With his announcement signals the company’s on the right track with gaining approval with the U.S. Food and Drug ...

Read More

$KALV +114% on public offering

$KALV is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Here is the link of the press release.   Here is the graph of the day.     Here is the 30 day overview.

Read More

EMAIL SIGNUP